Trial intelligence / Profile preview

STAK: Exogenous Ketones in Obesity

NCT06449287Completed

Sponsor
The Ohio State University
Start
Jul 2018
Primary completion
Mar 2019
Countries
1
01

Overview

Randomised, double-blind trial (3 arms), sponsored by The Ohio State University. Primary endpoints: Daily Ketone/Glucose Monitoring up to 6 weeks, Cholesterol up to 6 weeks and 4 more. Started Jul 2018; status: completed.

Beyond the preview

Go deeper on NCT06449287.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06449287.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call